CIK 0001585364
- Large accelerated filer
PERRIGO Co plc
Sign in to watch- Ticker
- PRGO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +1 269-673-8451
- Business address
- THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
- Former names
- PERRIGO Co Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-05 | Kochan Sharon EVP & President Rx | Grant or award · Restricted Stock Units | +8,041 | 8,041 | ||
| 2021-03-05 | SILCOCK RAYMOND EVP, Chief Financial Officer | Option exercise | +3,629 | $41.04 | $149K | 6,232 |
| 2021-03-05 | SILCOCK RAYMOND EVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +14,620 | 14,620 | ||
| 2021-03-05 | Sorota Richard S EVP & President CSCA | Option exercise | +2,540 | $41.04 | $104K | 10,053 |
| 2021-03-05 | Sorota Richard S EVP & President CSCA | Shares withheld for taxes | +1,108 | $41.04 | $45K | 11,161 |
| 2021-03-05 | Sorota Richard S EVP & President CSCA | Grant or award · Restricted Stock Units | +10,965 | 10,965 | ||
| 2021-03-05 | Farrington Thomas EVP and CIO | Option exercise | +1,469 | $41.04 | $60K | 17,814 |
| 2021-03-05 | Farrington Thomas EVP and CIO | Shares withheld for taxes | −607 | $41.04 | $25K | 17,207 |
| 2021-03-05 | Farrington Thomas EVP and CIO | Option exercise | +1,261 | $41.04 | $52K | 18,468 |
| 2021-03-05 | Farrington Thomas EVP and CIO | Shares withheld for taxes | −640 | $41.04 | $26K | 17,828 |
| 2021-03-05 | Farrington Thomas EVP and CIO | Grant or award · Restricted Stock Units | +5,080 | 5,080 | ||
| 2021-03-05 | Dillard James E III EVP, Chief Scientific Officer | Option exercise | +2,326 | $41.04 | $95K | 9,843 |
| 2021-03-05 | Dillard James E III EVP, Chief Scientific Officer | Shares withheld for taxes | −666 | $41.04 | $27K | 9,177 |
| 2021-03-05 | Dillard James E III EVP, Chief Scientific Officer | Option exercise | +1,996 | $41.04 | $82K | 11,173 |
| 2021-03-05 | Dillard James E III EVP, Chief Scientific Officer | Shares withheld for taxes | −570 | $41.04 | $23K | 10,603 |
| 2021-03-05 | Dillard James E III EVP, Chief Scientific Officer | Grant or award · Restricted Stock Units | +8,041 | 8,041 | ||
| 2021-03-05 | Willis Robert EVP & CHRO | Option exercise | +580 | $41.04 | $24K | 3,539 |
| 2021-03-05 | Willis Robert EVP & CHRO | Shares withheld for taxes | −302 | $41.04 | $12K | 3,237 |
| 2021-03-05 | Willis Robert EVP & CHRO | Option exercise | +550 | $41.04 | $23K | 4,121 |
| 2021-03-05 | Willis Robert EVP & CHRO | Shares withheld for taxes | −286 | $41.04 | $12K | 3,835 |
Page 42 of 47 · 921 trades